Post-synthetic enzymatic hypermethylation of DNA was induced in hamster fibrosarcoma cells by the DNA synthesis inhibitors cytosine arabinoside, hydrosyurea and aphidicolin. This effect required direct inhibition of DNA polymerase a or reduction in deoxynucleotide pools and was not specific to a single cell type. At equivalently reduced levels of DNA synthesis, neither cyclobeximide, actinomycin D nor serum deprivation affected DNA methylation in this way. The topoisomerase inhibitors nalidixic acid and novobiocin caused significant hypomethylation indicating that increased 5-mCyt content was not a necessary consequence of DNA synthesis inhibition.
INTRODUCTION
Drug-mediated hypermetbylation of DNA has also been reported. Following the initial findings of Burdon and Adams (12) and Kappler (13) that DNA methylation continues during inhibition of DNA synthesis, we (9) and others (14) have shown that cytosine arabinoside (araCyt), a chemotherapeutic agent which is a potent inhibitor of DNA synthesis, induces significant hypermethylation of the genome. It has also been reported that low dose araCyt induces differentiation of malignant myeloid cells (15) .
Drug-mediated hypermethylation might induce the switching off of genes. Besides being of theoretical interest, this concept could have important implications regarding the aberrant gene expression characteristic of tumor cells (16) (17) (18) (19) . We therefore extended our previous work to include 2 further "direct" inhibitors of DNA synthesis, hydroxyurea (HU) and aphidicolin. HU is an inhibitor of ribonucleotide reductase and depletes deoxyribonucleotide pools (20) ; aphidicolin is a specific inhibitor of DNA-a polymerase and blocks the dCTP binding site of this enzyme (21) . Both HU and aphidicolin have been shown to suppress the polymerization of newly synthesized DNA, resulting in the accumulation of low molecular weight DNA fragments (22) (23) (24) . Over extended periods of synthesis inhibition (e.g., 24 h), a small percentage of these low molecular weight fragments undergo successful ligation to high molelcular weight DNA characteristic of the mature polymer (24). We analyzed the relative degrees of methylation within these low molecular weight fragments compared to bulk DNA by isolating nascent DNA from mature high molecular weight polymer. This was accomplished by a procedure originally designed for the selective extraction of polyoma DNA from host cells (25) and later modified to enable the she separation of newly replicated versus mature eukaryotic DNA (26). Prechromosomal fragments and bulk DNA isolated in this way were compared for total 5-mCyt content and dinucleotide specificity of the hypermethylation phenomenon. The effects upon DNA methylation of cycloheximide-mediated inhibition of peptide synthesis, of actinomycin-D-mediated inhibition of mRNA synthesis, of depletion of required growth factors by serum deprivation, and of nalidixic acid and novobiocin-mediated inhibition of topoisomerase activity were also investigated.
We report here that DNA hypermethylation (1) required the direct inhibition of a-polymerase or of deoxyribonucleotide synthesis; (2) occurred to the greatest extent within low molecular weight DNA fragments synthesized during the presence of inhibitor; (3) occurred primarily within the heritable dinucleotide CpG, although other dinucleotides were overmethylated as well; and (4) could be induced in a number of cell types of both murine and human origin. The implications of drug-induced CpG hypermethylation for modulating gene expression are discussed.
MATERIALS AND METHODS

Cells and Media
Syrian hamster A(Tl)Cl-3 fibrosarcoma cells (27) (Table 3) suggesting that not only was DNA hypermethylation maintained in the absence of inhibitor, but that cytosines incorporated in the presence of drug were further methylated during the postlabelling period. This effect was not as evident in the DNA from aphidicolin-treated cells (Table 3) (Table  4) . Ratios of A+T/G+C obtained from limit enzymatic digests of DNA to 5'-deoxymononucleotides showed no bias toward the synthesis of sequences enriched in cytosine and guanine in treated vs control cultures. The hypermethylation response during inhibition of DNA synthesis was therefore not due to the selective synthesis of DNA of inherently greater methyl-accepting capacity. Exposure of cells to concentrations of the topoisomerase inhibitors nalidixic acid or novobiocin that inhibited DNA synthesis to levels comparable to those observed with araCyt, HU or apbidicolin induced significant DNA hypomethylation. Since topoisomerase enzymes regulate the topological conformation of DNA (36,37), this result suggests that DNA methylation is a supercoil-dependent phenomenon. This is particularly interesting in view of the finding that DNA methylation itself does not seem to alter the degree of supercoil formation in cellular DNA (38). It therefore appears from our limited data that a certain topological conformation may provide the best substrate for metbylase action. Vardimon and Rich (39) found that poly (dGpdC) plasmid inserts capable of undergoing transition to Z-form DNA were very poor substrates for prokaryotic Hha I methylase. Our results suggest that eukaryotic methylases prefer DNA substrates that have been exposed to nalidixate-or novobiocin-sensitive topoisomerase action.
Treatment of cells with HU or aphidicolin leads to the accumulation of low MW
The stimulation of DNA methylation induced by HU may have particular significance in our ability to silence eukaryotic genes because such hypermethylation was found to be stable in the absence of drug. Although only a small fraction (+6%) of the total genome became methylated during inhibitor treatment, the predominant sequence modified was found to be the normal methyl-acceptor CpG. Assuming sufficient methylase activity within the cell to maintain hypermethylated CpGs, these sequences may prove to be heritable. However, most of the hypermethylation was observed in the Hirt supernatant; since a substantial portion of this low molecular weight DNA made in the presence of HU does not join bulk chromosomal DNA (24), some of these sequences may be permanently lost from the genome. 
